New resolution on medicinal products and medical devices in the TTIP

Health technologies

Today, TACD releases a new policy resolution on medicinal products and medical devices (considered as health technologies by WHO) in the Trans-Atlantic Trade and Investment Partnership (TTIP). The resolution offers a set of recommendations to the EU and US negotiators, stressing that TTIP should under no circumstances reinforce the monopoly power of pharmaceutical corporations, limit the freedom …

Read More →